Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
Markets
/
Stocks
/
nasdaq-evmn
/
Evommune Inc
EVMN
19.600
USD
+0.020
+0.10%
Close 01/27, 16:00(ET)
Quotes delayed by 15 min
19.060
USD
+19.060
After-hours 01/27, 20:00 (ET)
589.52M
Market Cap
Loss
P/E TTM
Evommune Inc
19.600
+0.020
+0.10%
Overview
Company
Financials
Analysis
Overview
Company
Financials
Analysis
More Details of Company
Evommune Inc Info
Ticker Symbol
- -
Company name
- -
IPO date
- -
CEO
- -
Number of employees
- -
Security type
- -
Fiscal year-end
- -
Address
- -
City
- -
Stock exchange
- -
Country
- -
Postal code
- -
Phone
- -
Website
- -
Ticker Symbol
- -
IPO date
- -
CEO
- -
Company Executives of Evommune Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Eugene A. Bauer, M.D.
Dr. Eugene A. Bauer, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
284.94K
-1478.00%
Ms. Janice Drew
Ms. Janice Drew
Executive Vice President - Operations
Executive Vice President - Operations
33.32K
-5074.00%
Mr. Arthur S. Kirsch
Mr. Arthur S. Kirsch
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Luis Pena
Mr. Luis Pena
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Benjamin F. (Ben) McGraw, III
Dr. Benjamin F. (Ben) McGraw, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kyle B. Carver, CPA
Mr. Kyle B. Carver, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
--
--
Dr. Jeegar P. Patel, Ph.D.
Dr. Jeegar P. Patel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Francois Beaubien, Ph.D.
Dr. Francois Beaubien, Ph.D.
Director
Director
--
--
Dr. David Eric Cohen, M.D.
Dr. David Eric Cohen, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Eugene A. Bauer, M.D.
Dr. Eugene A. Bauer, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
284.94K
-1478.00%
Ms. Janice Drew
Ms. Janice Drew
Executive Vice President - Operations
Executive Vice President - Operations
33.32K
-5074.00%
Mr. Arthur S. Kirsch
Mr. Arthur S. Kirsch
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Luis Pena
Mr. Luis Pena
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Benjamin F. (Ben) McGraw, III
Dr. Benjamin F. (Ben) McGraw, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kyle B. Carver, CPA
Mr. Kyle B. Carver, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
EQT Life Sciences
15.64%
Pivotal Bioventure Partners Investment Advisor LLC
10.68%
RA Capital Management, LP
7.01%
Andera Partners S.A.S.
6.02%
SymBiosis II, L.L.C.
4.06%
Other
56.59%
Shareholders
Shareholders
Proportion
EQT Life Sciences
15.64%
Pivotal Bioventure Partners Investment Advisor LLC
10.68%
RA Capital Management, LP
7.01%
Andera Partners S.A.S.
6.02%
SymBiosis II, L.L.C.
4.06%
Other
56.59%
Shareholder Types
Shareholders
Proportion
Venture Capital
33.33%
Corporation
7.57%
Private Equity
6.02%
Individual Investor
4.59%
Other
48.50%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
4
12.40M
0.00%
--
2025Q4
4
12.40M
39.35%
+12.40M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
EQT Life Sciences
4.93M
15.64%
+4.93M
--
Nov 07, 2025
Pivotal Bioventure Partners Investment Advisor LLC
3.37M
10.68%
+3.37M
--
Nov 06, 2025
RA Capital Management, LP
2.21M
7.01%
+2.21M
--
Nov 06, 2025
Andera Partners S.A.S.
1.90M
6.02%
+1.90M
--
Nov 07, 2025
SymBiosis II, L.L.C.
1.28M
4.06%
+1.28M
--
Nov 06, 2025
B Capital Group Management LP
1.10M
3.5%
+1.10M
--
Nov 06, 2025
Beaubien (Francois Ph.D.)
589.00K
1.87%
+589.00K
--
Nov 06, 2025
Pena (Luis C)
489.90K
1.55%
-28.14K
-5.43%
Dec 09, 2025
Bauer (Eugene A)
284.94K
0.9%
-1.48K
-0.52%
Dec 09, 2025
Drew (Janice Suzann)
33.32K
0.11%
-5.07K
-13.22%
Dec 09, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI
Please log in to use KeyAI
Log in
Sign Up